Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone-Reference-Cited by-同舟云学术

Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone

Author:

Hosseinzadeh Hossein¹,Tavakkoli Alireza²,Mahdian Vahid³,Razavi Bibi Marjan⁴

Affiliation:

1. 4 Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2. 1 Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

3. 2 Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

4. 3 Department of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Funder

Korea Federation of Science and Technology Societies(KOFST)

Publisher

Korean Pharmacopuncture Institute

Subject

Complementary and alternative medicine,Pharmacology

Reference111 articles.

1. Review of pharmacological and toxicological effects of Nigella sativa and its active constituents;Ziaee;J Med Plants,2012

4. The protective effect of Nigella sativa against liver injury: a review;Mollazadeh;Iran J Basic Med Sci,2014

5. Cardio-protective and anti-cancer therapeutic potential of Nigella sativa;Shafiq;Iran J Basic Med Sci,2014

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献